Representative Investment Banking Engagements

Below is a list of representative Growthink Securities engagements and transactions.

For a more comprehensive list of previous and ongoing engagements, click here.

Accelerant Networks

Growthink ran an auction process for the sale of the semiconductor company. Through Growthink's efforts, Accelerant was sold to Synopsis for an eight-figure sum in February 2004. Nine-month assignment.

back to the top

Authenticlick

Los Angeles-based provider of pay-per-click advertising audit and fraud detection technology. Growthink assisted company management in drafting the business plan and refining the business model, made introductions to investment partners, and facilitated a financing transaction.

back to the top

FreeConference.com

Growthink co-led the auction process that resulted in a mid-8 figure sale of the telecommunications company to American Capital Partners (NASDAQ: ACAS), a publicly traded buyout and mezzanine fund with capital resources of approximately $7.7 billion.

back to the top

Hallmark Lighting

Growthink Securities acted as the broker-dealer in the sale of the custom lighting manufacturer to a strategic acquirer.

back to the top

Research Scientists

Growthink advised Research Scientists, a contract research organization, on its sale to Research Pharmaceutical Services, a large pharmaceuticals contract research solutions provider, for $7,500,000.

back to the top

Telverse

Growthink assisted Telverse, a Voice over IP (VoIP) software company, in raising its first venture capital round. The company was subsequently sold to Level 3 Communications in 2005 for a mid-8 figure sum.

back to the top

Thrombovision

ThromboVision, Inc. provides biomedical research and development services. It develops diagnostic solutions for healthcare practitioners for anti-platelet therapy and cardiovascular risk assessment and modification. The company’s product, ThromboGuide (T-Guide), provides platelet aggregation measuring services and identifies and monitors the function of platelets and how they are affected by anti-platelet drugs, is in the late-stage development. ThromboVision is based in Houston, Texas. In September 2007, Thrombovision completed a $4 million Series A convertible preferred stock financing. Growthink advised on the investor promotion process and introduced Thrombovision to private equity firm National Healthcare Services, who led the round.

back to the top

Tollgate Venture LLC

Growthink assisted Tollgate Venture LLC in consummating a $35 million financing toward the construction of hotel and casino with Century Casinos, Inc. (NASDAQ: CNTY) in Central City, Colorado.

back to the top

XCOM Wireless

Growthink developed the strategic business plan for XCOM, a Long Beach, CA-based high-technology start-up. XCOM develops radio frequency (RF) MEMS technology for improved signal routing. Growthink drafted the XCOM Wireless business plan and introduced XCOM to Ardesta Venture Capital of Ann Arbor, MI, with whom they completed their Series A financing round.

back to the top